Home › Funds › Ghisallo Capital Management LLC › ORKA

Ghisallo Capital Management LLC position in ORKA

ORUKA THERAPEUTICS INC · Health Care

Ghisallo Capital Management LLC reported holding 300,000 shares of ORKA (ORUKA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$25.0M, representing 0.57% of its reported portfolio and ranking #26 among its reported holdings. Ghisallo Capital Management LLC has disclosed ORKA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)300.00K sh
Reported value held$24.99M
Portfolio Weight0.57%
First reportedQ2 2026
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Ghisallo Capital Management LLC's ORKA position evolved

Ghisallo Capital Management LLC first disclosed a stake in ORKA in Q2 2026 at 50,000 shares (US$4.8M). The position peaked in Q3 2026 at 300,000 shares, worth US$25.0M. Across 2 filings, Ghisallo Capital Management LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 300,000 shares valued at US$25.0M — an increase of 250,000 shares quarter over quarter.. Notable position changes include a 500% increase in Q3 2026 (shares rose 26% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 50.00K $4.76M New
Q3 2026 300.00K $24.99M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ORKA and 13F data

ORKA (ORUKA THERAPEUTICS INC) is a Health Care company. 76 other funds we track also report a position in ORKA — the largest reported positions include Venrock Adviser, LLC (US$394.8M), Fairmount Funds Management LLC (US$352.6M), RTW INVESTMENTS, LP (US$261.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ORKA

All ORKA fund holders →

FAQ

How long has Ghisallo Capital Management LLC held ORKA?

Ghisallo Capital Management LLC has disclosed ORKA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Ghisallo Capital Management LLC's current position in ORKA?

As of Q3 2026, Ghisallo Capital Management LLC holds 300.00K shares of ORKA (ORUKA THERAPEUTICS INC), valued at $24.99M, representing 0.57% of its reported portfolio and ranking #26.

Has Ghisallo Capital Management LLC been buying or selling ORKA?

In the latest 13F filing (Q3 2026), Ghisallo Capital Management LLC increased its position in ORKA. The position peaked in Q3 2026 at 300.00K shares.

Which other funds hold ORKA?

Other major institutional holders of ORKA include Venrock Adviser, LLC, Fairmount Funds Management LLC, RTW INVESTMENTS, LP, among 76 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.